CEL-SCI highlights biological rationale for the use of Multikine in the Confirmatory Registration Head and Neck Cancer Study.

Data shows strong overall survival, progression-free survival, and durability from novel combination of efti in combination with pembrolizumab in ...

CEL-SCI (CVM) highlighted biological rationale for the use of Multikine in the confirmatory registration head and neck cancer study. This study ...

Researchers have developed a new technique for head and neck reconstruction using a pedicled latissimus dorsi flap. This ...

Osaka Metropolitan University researchers have developed a promising technique for head and neck reconstruction that shifts the placement of transferred tissue with blood vessels attached, offering a ...

Enfortumab vedotin may be a treatment option for patients with advanced head and neck cancer that is not amenable to definitive local therapy, researchers say. They reported phase 2 results with ...

In less than 18 months since its inception, the Punyashlok Ahilyadevi Holkar Head & Neck Cancer Institute of India near ...

Rhod Gilbert has shared that he is still facing some problems with his health following his cancer ordeal, but counts himself ...

For patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) with a contraindication for cis ...

With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...

Welsh comedian Rhod Gilbert has spoken about the long-term health problems that he is still facing following his cancer ...

Immutep (ASX:IMM) has announced promising new data from its Phase IIb TACTI-003 trial, presented at the ESMO Immuno-Oncology Congress 2024.